This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link. Do Not Sell My Personal Information

The “ALS Functional Rating Scale“(ALS-FRSr) is an internationally established scale for assessing ALS disease severity, which evaluates 12 motor functions (subscales) that are typically impaired in ALS. Since March 2017, we have been offering people with ALS the opportunity to document their individual ALS-FRSr scale online at regular intervals. By repeatedly answering the scale at…

At this year’s 90th Congress of the German Society of Neurology (DGN) from September 20 to 23 in Leipzig, we will show how outpatient partners in neurological palliative care can use “digital intelligence” to offer new and better care services for some partners. One of our highlights is the development and establishment of a care…

Ambulanzpartner receives research funding from the Federal Ministry of Education and Research (BMBF) for a project on technical care support for people with amyotrophic lateral sclerosis (ALS). In the ROBINA project, five companies are researching a new type of adaptive human-technology interaction concept together with ambulance partners. The aim of the project is to transfer…

Medication management comprises the control and monitoring of the medication process from prescription to administration of the medication. Medication management can be used to identify and rectify application errors, adherence problems or adverse drug events. Cross-professional medication management also includes medical (e.g. diagnoses) and nursing (e.g. care, care level) data. This allows medication to be…

AmbulanzPartner is featured in the current issue of the specialist journal NeuroTransmitter (1/2016 supplement). NeuroTransmitter sees itself as a discussion forum and leading professional-political medium for neurologists, neurologists and psychiatrists in Germany. As the organ of three professional associations, NeuroTransmitter is a must-read for neurologists and neurologists. Our aim with this article is to provide…

In the second phase of the study on post-rehabilitative disability due to stroke and patient needs (“MAS II“), AmbulanzPartner will be used to digitally record the long-term care of the study participants. MAS II is being conducted by the Charité’s Center for Stroke Research Berlin (CSB) and will begin in June 2016. The CSB wants…
A first scientific evaluation of aggregated care data from the Outpatient Partner Network was published this month in “Der Nervenarzt” – the official publication of the German Society of Neurology (DGN). The publication analyzes data on the provision of assistive devices for patients with amyotrophic lateral sclerosis (ALS) in the period from June 2011 to…

The Berlin Technology Foundation organized a press trip with Berlin’s Senator for Health and Social Affairs, Mario Czaja, together with AmbulanzPartner to present the “Smart Home Berlin” study on 01.04.2015. During the press trip, AmbulanzPartner was presented as an example of an innovative care technology developed in Berlin. The recently published study “Smart Home Berlin”…